Management of Mild Peripheral Vascular Disease

Exercise Therapy

• The American College of Cardiology recommends supervised exercise training as the first-line treatment for patients with mild peripheral vascular disease, particularly those with intermittent claudication 1, 4
• The exercise program should include a duration of 30-45 minutes per session, frequency of at least 3 sessions per week, and a minimum program length of 12 weeks 3, 4
• Walking to near-maximal pain is the most effective exercise type for improving walking ability and functional status in patients with mild peripheral vascular disease 4

Pharmacological Management

Antiplatelet Therapy

• The American College of Cardiology recommends aspirin (75-325 mg daily) for all patients with symptomatic peripheral vascular disease to reduce the risk of myocardial infarction, stroke, and vascular death 2, 3
• Clopidogrel (75 mg daily) is an effective alternative to aspirin for reducing cardiovascular events in patients with peripheral vascular disease 3

Lipid Management

• The American College of Cardiology recommends statin therapy for all patients with peripheral vascular disease, regardless of cholesterol levels, with a target LDL-C of <70 mg/dL for high-risk patients 1, 2

Blood Pressure Control

• The American College of Cardiology recommends antihypertensive therapy for patients with hypertension and peripheral vascular disease to reduce cardiovascular events, with a target blood pressure of <140/90 mmHg (or <130/80 mmHg if diabetes or chronic kidney disease is present) 1, 2
• Angiotensin-converting enzyme inhibitors or angiotensin-receptor blockers are particularly effective in reducing cardiovascular events in patients with peripheral vascular disease 2, 9

Smoking Cessation

• The American College of Cardiology recommends that patients who smoke be advised to quit smoking at every visit, with a comprehensive smoking cessation plan that includes behavioral counseling, pharmacotherapy options (varenicline, bupropion, and/or nicotine replacement therapy), and referral to a smoking cessation program 1, 2, 7

Diabetes Management

• The American College of Cardiology recommends optimizing glycemic control with a target hemoglobin A1C <7% for patients with diabetes and peripheral vascular disease 3, 7
• Proper foot care is essential for patients with diabetes and peripheral vascular disease, including appropriate footwear, daily foot inspection, skin cleansing, and prompt treatment of any skin lesions or ulcerations 3, 8

Follow-up and Monitoring

• Regular follow-up visits should be scheduled at least annually to assess clinical and functional status, medication adherence, cardiovascular risk factors, and disease progression with periodic ankle-brachial index measurements 6